BIRC5 and breast cancer: We have reported that the levels of autoantibodies to p53, p16, IMP2/p62, IMP3, BIRC5/Survivin, and HSP60 were elevated in the sera from patients with hepatocellular carcinoma [8,9,10], breast cancer [11], and lung cancer [12].